The late medical effects of cancer treatments

This 1-day medical cancer conference will focus on the 'medical' late effects of cancer treatments and provide a forum to discuss best practice.

Data shows that 40–45% of people should expect a cancer diagnosis in their lifetime. The number of patients who have survived cancer is also growing and so it is estimated that some 500,000 people are living with the actual and long-term consequences of cancer therapy.

With these statistics and with an ageing population, it is increasingly likely that all physicians will see patients who have survived cancer and are living with the late effects.

Programme highlights

scale and nature, and the patient's perspective of the problem
the systemic effects of cancer treatment – endocrine, respiratory, cardiac and exercise
bone metabolism
research in late effects
cancer as a chronic disease
how to do late effects of cancer treatment care well.

Really good, high quality conference with lots of ideas and thoughts to take back to my colleagues.

2015 delegate

Call for abstracts

We invite submissions of abstracts to be considered for poster presentation at the conference. All successful abstracts must be presented at the conference at an attended poster session. Therefore, at least one member of the team submitting the abstract will be expected to register and pay as a full delegate.

Abstracts may be published in print or online. By submitting an abstract, authors are agreeing to publication.

Abstracts should be submitted by email to conferences@rcplondon.ac.uk by midnight on 18 July 2016, accompanied by an abstract submission form. For further details please download the documents at the bottom of the page. For clinical cases please use the clinical case abstract template.

Who should attend

consultants and trainees from all medical specialties – in particular, endocrinology, cardiology and neurology
medical and clinical oncologists
paediatric oncologists
GPs.

This workshop is co-badged by: